Potential new cardiovascular risk factors: left ventricular hypertrophy, homocysteine, lipoprotein(a), triglycerides, oxidative stress, and fibrinogen.
about
Repeatability and measurement error in the assessment of choline and betaine dietary intake: the Atherosclerosis Risk in Communities (ARIC) studyMeasurement of left ventricular mass by contrast ventriculography.Growth hormone and the heart.Assessment of lower limb ischemia with measurement of skin perfusion pressure in patients on hemodialysis.Evidence based management of hypertension. Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based reviewIdentifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.The role of lipoprotein[a] in atherosclerosis.The effect of bisphenol A on some oxidative stress parameters and acetylcholinesterase activity in the heart of male albino ratsLipoprotein(a): an emerging cardiovascular risk factor.Ameliorate Effects of Li-Fu Formula on IL-6-Mediated Cardiac Hypertrophy in Hamsters Fed with a Hyper-Cholesterol DietAttenuated cardiac mitochondrial-dependent apoptotic effects by li-fu formula in hamsters fed with a hypercholesterol diet.Multiple low-dose radiation prevents type 2 diabetes-induced renal damage through attenuation of dyslipidemia and insulin resistance and subsequent renal inflammation and oxidative stress.Aortic unfolding determined using non-contrast cardiac computed tomography: correlations with age and coronary artery calcium scoreAdditive protection by LDR and FGF21 treatment against diabetic nephropathy in type 2 diabetes model.The Correlation Between Small Dense LDL and Reactive Oxygen Metabolites in a Physical Activity Intervention in Hyperlipidemic Subjects.Homocysteine and cardiovascular disease: a review of current recommendations for screening and treatment.Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease.Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.Dialysis patients and cardiovascular problems: can technology solve the complex equation?Oxidative Stress Biomarkers and Left Ventricular Hypertrophy in Children with Chronic Kidney DiseaseAcromegaly and the cardiovascular system.Cardiovascular complications of obesity in adolescents.Plasma homocysteine in adolescents depends on the interaction between methylenetetrahydrofolate reductase genotype, lipids and folate: a seroepidemiological study.The cardiac-specific nuclear delta(B) isoform of Ca2+/calmodulin-dependent protein kinase II induces hypertrophy and dilated cardiomyopathy associated with increased protein phosphatase 2A activity.A New Transgenic Mouse Model of Heart Failure and Cardiac Cachexia Raised by Sustained Activation of Met Tyrosine Kinase in the Heart.Pulmonary oxidative stress, inflammation, and dysregulated iron homeostasis in rat models of cardiovascular disease.Malondialdehyde, glutathione peroxidase and superoxide dismutase in peripheral blood erythrocytes of patients with acute cerebral ischemia.Panax notoginseng (Burk.) effects on fibrinogen and lipid plasma level in rats fed on a high-fat diet.Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction.Renal transplant recipients with coronary artery disease exhibit impairment in fibrinolysis and structural changes in carotid arteries.Strain-dependent beta-adrenergic receptor function influences myocardial responses to isoproterenol stimulation in mice.The value of apolipoprotein B/A1 ratio in the diagnosis of metabolic syndrome in a Korean population.Temporal association between pulmonary and systemic effects of particulate matter in healthy and cardiovascular compromised rats.
P2860
Q21245896-CD44DDC7-29B4-4A9B-8AA1-A064EF7D27B3Q30446578-A089F8EB-4413-4F9D-B313-ADA87C7BE797Q32026861-6841613A-3BB5-4E74-B65E-BA3E4BB8C020Q33284441-F2902BB2-D1DC-4874-B5D4-4321E0660BDFQ33805103-7B5CF08E-0C1E-4BA0-AB19-B87B526871ADQ34030905-3EBACA7D-C135-4C5D-84D6-46D07E942AD0Q34107432-14360B3D-8ACE-4F61-A76C-4AA9DA32E8BFQ34962315-20FA2812-DBE9-441F-891C-C6A260595C4BQ35081894-DC9977DE-6D4E-48FE-9362-5DC7BC92D0ABQ35103217-4582D176-8E5E-45F9-B76B-88EB9802B006Q35103744-0B799B0B-0E3A-406C-837E-0CF6ADAF0AF8Q35126070-A6ED0A19-01A6-4707-B8EE-DF138F4D3EB7Q35155221-48B2A61B-5E92-4AD2-AF8D-E5011B36314FQ35813371-CA272B06-AC01-4F2C-BC5B-B3067987750EQ36038038-3575DD81-E83F-41AD-886C-9280C064DBA6Q36062139-327CDF37-A47F-45B3-8D90-D896930DF52BQ36069621-BE4C159D-8FEF-4BE5-9881-C67E00D26C0AQ36076365-281F7757-A6AD-40CB-AFC9-317AD2100D94Q36315162-C5FDFA16-D768-4724-975C-CE0A63D82DE2Q36538869-473D6CF8-3B0A-4271-B620-D12C7B1526CEQ36626490-F2A8A57F-8375-45CC-AB6A-6FA18E328429Q36743491-B923651D-CA78-4A28-9379-32A0A51DAA64Q37387455-2DD2093E-DA36-4B8B-B8AB-248038502F44Q42512411-955F8A28-F7E6-4C84-B785-73B70D570A20Q42745683-648FF809-5375-491E-90A2-2ECD221AF2A8Q43100126-43313A16-B2C0-4ADF-8856-98C0FEDF8162Q43709669-534F4DE9-3D5E-46FF-A523-B2DD339C061DQ44325257-38E8A7BA-30C5-443B-91B1-63F84B3A3ABEQ44448395-F47E16F3-F556-4FCF-BCDE-7B1EC35E892BQ45250874-D9D0A027-C621-48C6-931B-069AF30474F6Q45304589-AC1CF061-5DE3-44DC-91E9-80B311830137Q53392636-A3DC603C-2FE6-416B-97CC-012B5E2B8E1FQ53663625-DD806289-C9BC-4981-84DC-213B667D788D
P2860
Potential new cardiovascular risk factors: left ventricular hypertrophy, homocysteine, lipoprotein(a), triglycerides, oxidative stress, and fibrinogen.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Potential new cardiovascular r ...... dative stress, and fibrinogen.
@ast
Potential new cardiovascular r ...... dative stress, and fibrinogen.
@en
type
label
Potential new cardiovascular r ...... dative stress, and fibrinogen.
@ast
Potential new cardiovascular r ...... dative stress, and fibrinogen.
@en
prefLabel
Potential new cardiovascular r ...... dative stress, and fibrinogen.
@ast
Potential new cardiovascular r ...... dative stress, and fibrinogen.
@en
P921
P1476
Potential new cardiovascular r ...... dative stress, and fibrinogen.
@en
P2093
P304
P356
10.7326/0003-4819-131-5-199909070-00009
P407
P577
1999-09-01T00:00:00Z